Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Penumbra Inc PEN

Healthcare Medical Devices
Penumbra, Inc. is a healthcare company. The Company designs, develops, manufactures, and markets products and has a portfolio that addresses challenging medical conditions in markets with unmet need. It is focused on developing, manufacturing, and marketing products for use by specialist physicians and healthcare providers to drive improved clinical and health outcomes. It is focused on... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NYSE:PEN)

Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference

PR Newswire 4 days ago

New Late Breaking Data Show Patients Treated with Penumbra's Computer Assisted Vacuum Thrombectomy Technology for Pulmonary Embolism Experience Shorter Hospital Stays and Fewer Complications Compared to Other Treatment Options

PR Newswire November 5, 2024

Penumbra, Inc. Reports Third Quarter 2024 Financial Results

PR Newswire October 30, 2024

Penumbra, Inc. Announces Completion of THUNDER IDE Study Enrollment for Acute Ischemic Stroke

PR Newswire October 14, 2024

Penumbra, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call for October 30, 2024

PR Newswire October 2, 2024

Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy Technologies - Lightning Flash(TM) 2.0 and Lightning Bolt(TM) 7 - in Europe

PR Newswire September 16, 2024

Penumbra, Inc. to Present at the Baird Global Healthcare Conference

PR Newswire August 27, 2024

Penumbra, Inc. to Present at the Wells Fargo Healthcare Conference

PR Newswire August 21, 2024

Penumbra, Inc. Announces $200 Million Share Repurchase Authorization

PR Newswire August 13, 2024
View More News ››

Opinion & Analysis (NYSE:PEN)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NYSE:PEN)

PEN Price Target Alert: $235.00. Issued by Piper Sandler

News; $PEN PEN Price Target Alert: $235.00. Issued by Piper Sandler2024-10-31 08:59:42 ET Matt O'Brien from Piper Sandler issued a...
whytestocks - October 31, 2024

PEN Price Target Alert: $235.00. Issued by Truist Financial

News; $PEN PEN Price Target Alert: $235.00. Issued by Truist Financial2024-10-14 11:59:28 ET Richard Newitter from Truist Financial...
whytestocks - October 14, 2024

Pacemakers: Penumbra Is Out Of The Blocks Quickly In 2021

Embattled medical devices company Penumbra Inc. was quietly having an impressive 2021, market wise, before it got loud about it Monday,...
AwareInvestor - January 16, 2021

Cannabis Remedies

What are the potential of cannabis might give as health benefits? find our more to widen your vision!   CBD is a molecule, not...
Jakehim0904 - December 30, 2020

The Emperor’s Decree: Marcus Aurelius Has Some Thoughts Abou

Yesterday, the coalition of activist short sellers who have been nipping at the ankles of medical devices company Penumbra got some...
AwareInvestor - December 30, 2020

Short Report

Spruce Point Capital has a poor track record.   They get one day's worth of downside profit and then after that they move...
indoubtgetout - July 31, 2019
View more Bullboard ››

K9 Gold Corp

K9 Gold Corp

K9 Gold Corp. is engaged in the business of identification, acquisition and exploration of mineral interests. The Company’s ...
View More »